Quantum SQ
Storage & Handling
Store unopened lyophilized vials at room temperature
After reconstitution: refrigerate at 36–46°F
Use within 24 hours
Single-use only; discard unused portion
Maintain strict aseptic technique
Patient Eligibility & Safety
Review medical history, medications, allergies, and prior reactions
Avoid or use with caution in:
Active infection at injection site
Uncontrolled autoimmune disease
Active malignancy unless cleared
Pregnancy or breastfeeding (unless explicitly approved)
Obtain written informed consent including off-label disclosure
Record baseline vitals (HR, BP optional for SQ initiation)
Preparation
Reconstitution:
Reconstitute vial with 0.5-1mL sterile wateror sterile preferred normal saline
Inject slowly down vial wall
Gently swirl - do not shake
Ensure full dissolution before withdrawal
2. Syringe Preparation
Use insulin syringe (29–31g, 0.3–1 mL)
Withdraw prescribed volume
Expel air bubbles carefully
Administration - Subcutaneous Injection
Injection Sites
Abdomen (≥2 inches from umbilicus)
Love handles / flank
Upper outer thigh
Rotate sites with each injection
Technique
Clean site with alcohol prep
Pinch subcutaneous tissue
Insert needle at 45–90° angle
Inject slowly over 5–10 seconds
Withdraw needle, apply light pressure
Do not massage aggressively
Adverse Event Management
Mild
Local erythema, swelling, itching
Cold compress, oral antihistamine if needed
Rotate injection sites
Moderate
Lightheadedness, flushing, nausea
Hold dose, hydrate, reassess dosing frequency
Severe (Rare)
Anaphylaxis, chest tightness, dyspnea
Activate emergency protocol
Administer epinephrine, oxygen, EMS per ACLS guidelines
Regulatory Status
Quantum SQ administration is off-label
Intended for use only by licensed healthcare providers
Providers must be trained in injectable therapies and adverse-event management
Use within scope of state licensure and clinical practice guidelines